ResearcherUniversity of OxfordNo recent work listed

Xin Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6587-1152; OpenAlex author ID A5100719902. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer. Last author DOI 10.1038/s41418-023-01168-3 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paul Miller · 1 shared paper, 2023 · strength 0.17
- Paper p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer. DOI 10.1038/s41418-023-01168-3 ↗
Eric E. O’Neill · 1 shared paper, 2023 · strength 0.17
- Paper p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer. DOI 10.1038/s41418-023-01168-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.